Current treatments for scabies

Fundamental and Clinical Pharmacology

Volumn 17, Issue 2, 2003, Pages 217-225

  Buffet, M ^a   Dupin, N ^a  

^a Pavillon Tarnier Hosp Cochin ^*  (France)

Author keywords

Ivermectin; Scabies; Treatment

Indexed keywords

BENZYL BENZOATE; CROTAMITON; IVERMECTIN; LINDANE; PERMETHRIN; PLACEBO; PYRETHRIN; SULFIRAM;

ARTICLE; BLOOD TOXICITY; BURNING SENSATION; DRUG EFFICACY; DRUG TOLERANCE; ECTOPARASITE; EVIDENCE BASED MEDICINE; HUMAN; INFESTATION; IRRITANT DERMATITIS; LIFE CYCLE; NEUROTOXICITY; PATIENT COMPLIANCE; PRIORITY JOURNAL; PRURITUS; SCABIES; SURVIVAL;

ADMINISTRATION, ORAL; ADMINISTRATION, TOPICAL; ANIMALS; ANTIPARASITIC AGENTS; CLINICAL TRIALS; HUMANS; IVERMECTIN; SARCOPTES SCABIEI; SCABIES;

EID: 0037397572     PISSN: 07673981     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1472-8206.2003.00173.x     Document Type: Article

References (61)

1. Held E. Parasites et arthropodes, in: Saurat J.H., Grosshans E., Laugier P., Lachapelle J.M. (Eds), Dermatologie et maladies sexuellement transmissibles, Masson, Paris, 1999, pp. 160-162.
2. Orkin M. Scabies: what's new? Curr. Probl. Dermatol. (1995) 22, 105-111.
3. Chosidow O. Scabies and pediculosis. Lancet (2000) 355. 819-826.
4. Bigby M. A systematic review of the treatment of scabies. Arch. Dermatol. (2000) 136, 387-389.
5. Walker G.J.A., Johnstone P.W. Interventions for treating scabies. Cochrane Database Syst. Rev. (2000) 3, CD000320.
6. Bécherel P.-A., Barete S., Francès C., Chosidow O. Ectoparasitose (pédiculose et gale): stratégie thérapeutique actuelle. Ann. Dermatol. Venereol. (1999) 126, 755-761.
7. Walton S.F., Myerscough M.R., Currie B.J. Studies in vitro on the relative efficacy of current acaricides for Sarcoptes scabiei var. hominis. Trans. R. Soc. Trop. Med. Hyg. (2000) 94, 92-96.
8. Landegren J., Borglund E., Storgards K. Treatment of scabies with disulfiram and benzyl benzoate emulsion: a controlled study. Acta Derm. Venereol. (1979) 59, 274-276.
9. Pitche P., Wolkenstein P., Cremer G., Foulet F., Lascaux A.-S., Revuz J. Gale profuse: cinétique de guérison parasitologique avec l'association benzoate de benzyl et sulfiram. Ann. Dermatol. Venereol. (2002) 129, 287-289.
10. Taplin D., Meinking T.L., Porcelain S.L. Castillero P.M., Chen J.A. Permethrin 5% dermal cream: a new treatment for scabies. J. Am. Acad. Dermatol. (1986) 15, 995-1001.
11. Schultz M.W., Gomez M., Hansen R.C. et al. Comparative study of 5% permethrin cream and 1% lindane lotion for the treatment of scabies. Arch. Dermatol. (1990) 126, 167-170.
12. Taplin D., Meinking T.L., Chen J.A., Sanchez R. Comparison of crotamiton 10% cream (Eurax) and permethrin 5% cream (Elimite) for the treatment of scabies in children. Pediatr. Dermatol. (1990) 7, 67-73.
13. Franz T.J., Lehman P.A., Franz S.F., Guin J.D. Comparative percutaneous absorption of lindane and permethrin. Arch. Dermatol. (1996) 132, 901-905.
14. National Guideline on the Management of Scabies. Clinical effectiveness group (Association for Genitourinary Medicine and the Medical Society for the Study of Venereal Diseases). Sex. Transm. Infect. (1999) 75, S76-S77.
15. Orkin M., Maibach H.I. Scabies therapies. Semin. Dermatol. (1993) 12, 22-23.
16. Brown S., Becher J., Brady W. Treatment of ectoparasitosis infections: review of the English-language literature, 1982-1992. Clin. Infect. Dis. (1995) 20, S104-S109.
17. Rauch A.E., Kowalsky S.F., Lesar T.S., Sauerbier G.A., Burkart P.T., Scharfman W.B. Lindane (Kwell)-induced aplastic anemia. Arch. Intern. Med (1990) 150, 2393-2395.
18. Suwalsky M., Villena F., Marcus D., Ronco A.M. Plasma absorption and ultrastructural changes of rat testicular cells induced by lindane. Hum. Exp. Toxicol. (2000) 19, 529-533.
19. Konstantinov D., Stanoeva L., Yawalkar S.J. Crotamiton cream and lotion in the treatment of infants and young children with scabies. J. Int. Med. Res. (1979) 7, 443-448.
20. Burkhart C.G., Burkhart C.N. Optimal treatment for scabies remains undetermined. J. Am. Acad. Dermatol. (2001) 45, 637-638.
21. Victoria J., Trujillo R. Topical ivermectin: a new successful treatment for scabies. Pediatr. Dermatol. (2001) 18, 63-65.
22. Youssef M.Y., Sadaka H.A., Eissa M.M., el-Ariny A.F. Topical application of ivermectin for human ectoparasites. Am. J. Trop. Med. Hyg. (1995) 53, 652-653.
23. Del Giudice P., Marty P. Ivermectin: a new therapeutic weapon in dermatology. Arch. Dermatol (1999) 135, 705-706.
24. Caumes E. Ivermectine et dermatoses tropicales. Bull. Soc. Pathol. Exot. (1997) 90, 37-38.
25. Forstinger C., Kittler H., Binder M. Treatment of rosacea-like demodicidosis with oral ivermectin and topical permethrin cream. J. Am. Acad. Dermatol. (1999) 41, 775-777.
26. Macotela-Ruiz E., Pena-Gonzales G. The treatment of scabies with oral ivermectin. Gac. Med. Mex. (1993) 129, 201-205.
27. Glaziou P., Cartel J.L., Alzieu P., Briot C., Moulia-Pelat J.P., Martin P.M. Comparison of ivermectin and benzyl benzoate for treatment of scabies. Trop. Med. Parasitol. (1993) 44, 331-332.
28. Chouela E.N., Abeldaño A.M., Pellegrano G. Equivalent therapeutic efficacity and safety of ivermectin and lindane in the treatment of human scabies. Arch. Dermatol. (1999) 135, 651-655.
29. Madan V., Jaskiran K., Gupta U., Gupta D.K. Oral ivermectin in scabies patients: a comparison with 1% topical lindane solution. J. Dermatol. (2001) 28, 481-484.
30. Usha V., Gopalakrishnan Nair T.V. A comparative study of oral ivermectin and topical permethrin cream in the treatment of scabies. J. Am. Acad. Dermatol. (2000) 42, 236-240.
31. Meinking T.L., Taplin D., Hermida J.L., Pardo R., Kerdel F.A. The treatment of scabies with ivermectin. N. Engl. J. Med. (1995) 333, 26-30.
32. Dourmishev A., Serafimova D., Dourmishev L. Efficacity and tolerance of oral ivermectin in scabies. J. Eur. Dermatol. Venereol. (1998) 11, 247-251.
33. Conti Diaz I.A., Amaro J. Treatment of human scabies with oral ivermectin. Rev. Inst. Med. Trop. Sao Paulo (1999) 41, 259-261.
34. Offidani A., Cellini A., Simonetti O., Fumelli C. Treatment of scabies with ivermectin. Eur. J. Dermatol. (1999) 9, 100-101.
35. Nnoruka E.N., Agu C.E. Successful treatment of scabies with oral ivermectin in Nigeria. Trop. Doct. (2001) 31, 15-18.
36. Bredal W.P. Death associated with ivermectin for scabies. Lancet (1997) 350, 216.
37. Barkwell R., Shields S. Death associated with ivermectin treatment of scabies. Lancet (1997) 349, 1144-1145.
38. Diazgranados J.A., Costa J.L. Death after ivermectin treatment. Lancet (1997) 349, 1698.
39. Reintjes R., Hoek C. Death associated with ivermectin for scabies. Lancet (1997) 350, 215.
40. Coyne P.E., Addiss D.G. Death associated with ivermectin for scabies. Lancet (1997) 350, 215-216.
41. Del Giudice P., Marty P., Gari-Toussaint M., Le Fichoux Y. Ivermectin in elderly patients. Arch. Dermatol. (1999) 135, 351-352.
42. Witkowski J.A., Parish L.C. Scabies. Subungual areas harbor mites. JAMA (1984) 252, 1318-1319.
43. Dourmishev A.L., Serafimova D.K., Dourmishev L.A. Mualla M.A., Papaharalambous V., Malchevsky T. Crusted scabies of the scalp in dermatomyositis patients: three cases treated with oral ivermectin. Int. J. Dermatol. (1998) 37, 231-234.
44. Alinovi A., Pretto M.E. Scabietic infestation of the scalp: a clue for puzzling relapses. J. Am. Acad. Dermatol. (1994) 31, 492-493.
45. Taplin D., Meinking T.L. Treatment of HIV-related scabies with emphasis on the efficacy of ivermectin. Semin. Cutan. Med. Surg. (1997) 16, 235-240.
46. Del Giudice P., Caries M., Couppié P. et al. Successful treatment of crusted (Norvegian) scabies with ivermectin in two patients with human immunodeficiency virus infection. Br. J. Dermatol. (1996) 135, 494-495.
47. Corbett E.L., Crossley I., Holton J., Levell N., Miller R., De Cock K.M. Crusted ("Norvegian") scabies in a specialist HIV unit: successful use of ivermectin and failure to prevent nosocomial transmission. Genitourin Med. (1996) 72, 115-117.
48. Alberici F., Pagani L., Ratti G., Viale P. Ivermectin alone or in combination with benzyl benzoate in the treatment of human immunodeficiency virus-associated scabies. Br. J. Dermatol. (2000) 142, 969-972.
49. Dannaoui E., Kiazand A., Piens M., Picot S. Use of ivermectin for the management of scabies in a nursing home. Eur. J. Dermatol. (1999) 9, 443-445.
50. Sullivan J.R. Watt G., Barker B. Successful use of ivermectin in the treatment of endemic scabies in a nursing home. Australas. J. Dermatol. (1997) 38, 137-140.
51. Marty P., Gari-Toussaint M., Le Fichoux Y. Gaxotte P. Efficacity of ivermectin in the treatment of an epidemic of sarcoptic scabies. Ann. Trop. Med. Parasitol. (1994) 88, 453.
52. Ancelle T. Morice J.Tourte-Schaefer C. Investigation d'une épidémie de gale dans un centre de long et moyen séjiour pour personnes âgées de la région parisienne. 1995-1996. BEH (1997) 6, 23-26.
53. Marques-Santos L.F., Bernardo R.R., de Paula E.F., Rumjanek V.M. Cyclosporin A and trifluoperazine, two resistance-modulating agents, increase ivermectin neurotoxicity in mice. Pharmacol. Toxicol. (1999) 84, 125-129.
54. Leppard B., Naburi A.E. The use of ivermectin in controlling an outbreak of scabies in a prison. Br. J. Dermatol. (2000) 143, 520-523.
55. Huffam S.E., Currie B.J. Ivermectin for Sarcoptes scabiei hyper-infestation. Int. J. Infect. Dis. (1998) 2, 152-154.
56. Marliere V., Roul S., Labreze C., Taieb A. Crusted (Norwegian) scabies induced by use of topical corticosteroids and treated successfully with ivermectin. J. Pediatr. (1999) 135, 122-124.
57. Gladstone H.B., Darmstadt G.L. Crusted scabies in a immuno-competent child: treatment with ivermectin. Pediatr. Dermatol. (2000) 17, 154-156.
58. Aubin F., Humbert P. Ivermectin for crusted (norwegian) scabies. N. Engl. J. Med. (1995) 332, 612.
59. Jaramillo-Ayerbe F., Berrio-Munõz J. Ivermectin for crusted Norwegian scabies induced by use of topical steroids. Arch. Dermatol. (1998) 134, 143-145.
60. Ndiaye B., Develoux M., Dieng M.T. Crusted (Norwegian) scabies in Dakar (Senegal). Sante (1999) 9, 243-248.
61. Burkhart K.M., Burkhart C.N., Burkhart C.G. Comparing topical scabietic treatments will soon become extinct. Arch. Dermatol. (1997) 133, 1314.